Physician profile
Eric Chuang
NPI 1124140207
$1,483.04
in general payments reported to CMS, 2019-2025
8 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $142 · 2021: $19.19 · 2022: $285 · 2023: $137 · 2024: $151 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.11 |
| Education | $274.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $483.57 | 2019 | |
| Medical Device Business Services, INC. | $274.02 | 2023-2024 | Stratafix |
| Angiodynamics, INC. | $197.90 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $180.68 | 2025 | Diamondback Peripheral |
| Cardiovascular Systems INC. | $156.78 | 2022 | |
| Boston Scientific Corporation | $141.97 | 2020 | |
| Solventum Corporation | $28.93 | 2024-2025 | Abthera, Prevena, V.A.C. Veraflo |
| Melinta Therapeutics, LLC | $19.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.